Asia-Pacific Asthma Market “Will Hit $6 billion by 2023”
Pharma’s Reputation Nightmare Gets Marginally Better
New survey ranks the reputation of individual pharmaceutical companies.
Preparing for the Growth of the Biopharma Market
Great Oncology Products Don't "Guarantee Physician Satisfaction"
Customer Experience: A Buzz Term or a Source of Real Commercial Value?
Exploring the importance of a customer experience strategy (CXM) through a case study of a life science tools company.
Gottlieb Takes Reins at FDA, Big Issues Loom
New legislation, administration priorities raise multiple challenges for new commissioner.
EU Countries Square Up to Pharma on Prices
The recent EFPIA and EU health council conferences highlight the growing divisions-and resentments-between industry and governments in Europe.
Pharmaceutical Executive, June 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2017 issue in an interactive PDF format.
US Generics Market Set for More "Dynamic Growth"
FDA Approves Keytruda for Cancers with Specific Biomarker
WHO Names New Director-General
Growth Hormone Deficiency Market “Will Surpass $2 Billion by 2026”
Tackling Healthcare System Inefficiency in Europe
European Health Conference to Address "Populism and Post-Truth Politics"
eyeforpharma Conference Tackles Cross-Functional RWE
Indegene and Microsoft Deliver New CRM Solution
Ireland Reiterates Bid to Host European Medicines Agency
New End-to-End Analytics Platform Launched
CPhI Worldwide to Launch Global Pharma Market Ranking Index
German Pharmaceuticals Market Predicted Rise to $86.3 billion by 2021
AstraZeneca VP Shares Tips for Success
Among those honored at HBA’s Women of the Year awards luncheon, Bahija Jallal’s story is one of courage and resilience.
PhRMA Board Announces New Criteria for Membership
Veeva Releases News from Global Commercial & Medical Summit
Tufts CSDD Reports Significant Growth for New Biotech Products
Zephyr Health Announces Certification in Veeva CRM MyInsights
Global Immunology Market to Surpass $75 billion by 2022
Spain’s Pharma Market Remains Stable—Reaching $25 billion by 2021
Don’t be the Next #Hashtag
Recent PR disasters in other industries raise an important reputational question that can apply to pharma as well: do you want to be someone that works the system or improves the system?
Pharma supply chain "needs to get out of its silos"
New Life in European Drug Pricing Spat
Grant-boosted Euripid pushes revitalized defense of external reference pricing system.
